Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

11drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: HCB101 ×

HCB101

This drug is selected. Its supporting articles are shown below.

Articles mentioning HCB101

2 articles · page 1 of 1

1331 HCB101, a next-generation Fc-engineered anti-CD47 SIRPα fusion protein, demonstrates favorable safety and early antitumor activity in advanced cancers

jitc · abstract · 2025-11-07 · 6 matching annotations

99.0%

HCB101 ECOG Performance Status non-Hodgkin lymphoma TAIPEI VETERANS GENERAL HOSPITAL Institutional Review Board National Taiwan University Hospital Eastern Cooperative Oncology Group Hangzhou First People’s Hospital Ethics Committee

… 27, 2025, 55 participants (71% solid tumors, 29% NHL) received HCB101. Treatment-related adverse events (TRAEs) were manageable, most…

1332 Phase Ib/IIa study of HCB101 combined with standard therapies demonstrates manageable safety and dose-dependent antitumor activity in immunologically cold advanced solid tumors

jitc · abstract · 2025-11-07 · 5 matching annotations

97.6%

HCB101 HCB101-based HCB101-201 nab-paclitaxel ramucirumab paclitaxel toripalimab gastric cancer head and neck squamous cell carcinoma triple-negative breast cancer+1 more

… plus ramucirumab and paclitaxel); and b) first-line (1L) TNBC (HCB101 plus toripalimab and nab-paclitaxel). Primary endpoints were sa…